Global Remdesivir API Market Research Report 2024

Publication ID:

PB506246179

Publication Date:

June 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Remdesivir API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Remdesivir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remdesivir API.
Report Scope
The Remdesivir API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remdesivir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remdesivir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Beijing Mesochem Technology
Dalian Richon Chem
Huateng Pharma
Dr. Reddy's Laboratories
Ami Lifesciences
HONOUR LAB LTD
MSN Laboratories
Omgene Life Sciences
ZCL Chemicals Limite
Segment by Type
0.99
0.995
Others
Segment by Application
Medical Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remdesivir API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Remdesivir API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Remdesivir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Remdesivir API Market Overview
1.1 Product Definition
1.2 Remdesivir API Segment by Type
1.2.1 Global Remdesivir API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 0.99
1.2.3 0.995
1.2.4 Others
1.3 Remdesivir API Segment by Application
1.3.1 Global Remdesivir API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Remdesivir API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Remdesivir API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Remdesivir API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Remdesivir API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Remdesivir API Production Market Share by Manufacturers (2019-2024)
2.2 Global Remdesivir API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Remdesivir API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Remdesivir API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Remdesivir API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Remdesivir API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Remdesivir API, Product Offered and Application
2.8 Global Key Manufacturers of Remdesivir API, Date of Enter into This Industry
2.9 Remdesivir API Market Competitive Situation and Trends
2.9.1 Remdesivir API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Remdesivir API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Remdesivir API Production by Region
3.1 Global Remdesivir API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Remdesivir API Production Value by Region (2019-2030)
3.2.1 Global Remdesivir API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Remdesivir API by Region (2025-2030)
3.3 Global Remdesivir API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Remdesivir API Production by Region (2019-2030)
3.4.1 Global Remdesivir API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Remdesivir API by Region (2025-2030)
3.5 Global Remdesivir API Market Price Analysis by Region (2019-2024)
3.6 Global Remdesivir API Production and Value, Year-over-Year Growth
3.6.1 North America Remdesivir API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Remdesivir API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Remdesivir API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Remdesivir API Production Value Estimates and Forecasts (2019-2030)
4 Remdesivir API Consumption by Region
4.1 Global Remdesivir API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Remdesivir API Consumption by Region (2019-2030)
4.2.1 Global Remdesivir API Consumption by Region (2019-2024)
4.2.2 Global Remdesivir API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Remdesivir API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Remdesivir API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Remdesivir API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Remdesivir API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Remdesivir API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Remdesivir API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Remdesivir API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Remdesivir API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Remdesivir API Production by Type (2019-2030)
5.1.1 Global Remdesivir API Production by Type (2019-2024)
5.1.2 Global Remdesivir API Production by Type (2025-2030)
5.1.3 Global Remdesivir API Production Market Share by Type (2019-2030)
5.2 Global Remdesivir API Production Value by Type (2019-2030)
5.2.1 Global Remdesivir API Production Value by Type (2019-2024)
5.2.2 Global Remdesivir API Production Value by Type (2025-2030)
5.2.3 Global Remdesivir API Production Value Market Share by Type (2019-2030)
5.3 Global Remdesivir API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Remdesivir API Production by Application (2019-2030)
6.1.1 Global Remdesivir API Production by Application (2019-2024)
6.1.2 Global Remdesivir API Production by Application (2025-2030)
6.1.3 Global Remdesivir API Production Market Share by Application (2019-2030)
6.2 Global Remdesivir API Production Value by Application (2019-2030)
6.2.1 Global Remdesivir API Production Value by Application (2019-2024)
6.2.2 Global Remdesivir API Production Value by Application (2025-2030)
6.2.3 Global Remdesivir API Production Value Market Share by Application (2019-2030)
6.3 Global Remdesivir API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Beijing Mesochem Technology
7.1.1 Beijing Mesochem Technology Remdesivir API Corporation Information
7.1.2 Beijing Mesochem Technology Remdesivir API Product Portfolio
7.1.3 Beijing Mesochem Technology Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Beijing Mesochem Technology Main Business and Markets Served
7.1.5 Beijing Mesochem Technology Recent Developments/Updates
7.2 Dalian Richon Chem
7.2.1 Dalian Richon Chem Remdesivir API Corporation Information
7.2.2 Dalian Richon Chem Remdesivir API Product Portfolio
7.2.3 Dalian Richon Chem Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Dalian Richon Chem Main Business and Markets Served
7.2.5 Dalian Richon Chem Recent Developments/Updates
7.3 Huateng Pharma
7.3.1 Huateng Pharma Remdesivir API Corporation Information
7.3.2 Huateng Pharma Remdesivir API Product Portfolio
7.3.3 Huateng Pharma Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Huateng Pharma Main Business and Markets Served
7.3.5 Huateng Pharma Recent Developments/Updates
7.4 Dr. Reddy's Laboratories
7.4.1 Dr. Reddy's Laboratories Remdesivir API Corporation Information
7.4.2 Dr. Reddy's Laboratories Remdesivir API Product Portfolio
7.4.3 Dr. Reddy's Laboratories Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.5 Ami Lifesciences
7.5.1 Ami Lifesciences Remdesivir API Corporation Information
7.5.2 Ami Lifesciences Remdesivir API Product Portfolio
7.5.3 Ami Lifesciences Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Ami Lifesciences Main Business and Markets Served
7.5.5 Ami Lifesciences Recent Developments/Updates
7.6 HONOUR LAB LTD
7.6.1 HONOUR LAB LTD Remdesivir API Corporation Information
7.6.2 HONOUR LAB LTD Remdesivir API Product Portfolio
7.6.3 HONOUR LAB LTD Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 HONOUR LAB LTD Main Business and Markets Served
7.6.5 HONOUR LAB LTD Recent Developments/Updates
7.7 MSN Laboratories
7.7.1 MSN Laboratories Remdesivir API Corporation Information
7.7.2 MSN Laboratories Remdesivir API Product Portfolio
7.7.3 MSN Laboratories Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 MSN Laboratories Main Business and Markets Served
7.7.5 MSN Laboratories Recent Developments/Updates
7.8 Omgene Life Sciences
7.8.1 Omgene Life Sciences Remdesivir API Corporation Information
7.8.2 Omgene Life Sciences Remdesivir API Product Portfolio
7.8.3 Omgene Life Sciences Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Omgene Life Sciences Main Business and Markets Served
7.7.5 Omgene Life Sciences Recent Developments/Updates
7.9 ZCL Chemicals Limite
7.9.1 ZCL Chemicals Limite Remdesivir API Corporation Information
7.9.2 ZCL Chemicals Limite Remdesivir API Product Portfolio
7.9.3 ZCL Chemicals Limite Remdesivir API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 ZCL Chemicals Limite Main Business and Markets Served
7.9.5 ZCL Chemicals Limite Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Remdesivir API Industry Chain Analysis
8.2 Remdesivir API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Remdesivir API Production Mode & Process
8.4 Remdesivir API Sales and Marketing
8.4.1 Remdesivir API Sales Channels
8.4.2 Remdesivir API Distributors
8.5 Remdesivir API Customers
9 Remdesivir API Market Dynamics
9.1 Remdesivir API Industry Trends
9.2 Remdesivir API Market Drivers
9.3 Remdesivir API Market Challenges
9.4 Remdesivir API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Beijing Mesochem Technology
Dalian Richon Chem
Huateng Pharma
Dr. Reddy's Laboratories
Ami Lifesciences
HONOUR LAB LTD
MSN Laboratories
Omgene Life Sciences
ZCL Chemicals Limite

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂